b,b-Dimethylacrylshikonin (DMAS) is an anti-cancer compound extracted from the roots of Lithospermum erythrorhizon. The present study aims to investigate the effects of DMAS on human lung adenocarcinoma cells in vitro and explore the mechanisms of its anti-cancer action. We showed that DMAS markedly inhibited cell viability in a dose-and time-dependent way, and induced apoptosis as well as autophagy in human lung adenocarcinoma cells. Furthermore, we found that DMAS stimulated endoplasmic reticulum stress and mediated autophagy through the PERK-eIF2a-ATF4-CHOP and IRE1-TRAF2-JNK axes of the unfolded protein response in human lung adenocarcinoma cells. We also showed that the autophagy However, whether DMAS induces autophagy, and the role it plays in cell death in human lung adenocarcinoma cells, remain elusive. Autophagy is an evolutionarily conserved cellular self-
catabolic process, responsible for degrading and recycling unnecessary or damaged cytoplasmic components in a lysosome-dependent method for cell survival. 10 The process of autophagy begins with sequestering unnecessary byproducts or damaged organelles into autophagosomes that then fuse with lysosomes to form autolysosomes for degradation of inner cargoes. 11 Previous research suggested that numerous compounds could induce autophagy for cell survival or cell death by a variety of mechanisms (eg, salinomycin-induced cytoprotective autophagy in human lung cancer cells through the activation of endoplasmic reticulum stress, whereas isocryptotanshinone increased autophagic cell death in A549 lung cancer cells by inhibition of STAT3 activity). 12, 13 In the current study, the effects of DMAS on human lung adenocarcinoma cells in terms of cell viability, apoptosis, and autophagy were evaluated. Furthermore, the potential mechanisms involved in DMAS-induced apoptosis and autophagy were also investigated. F I G U R E 1 b,b-Dimethylacrylshikonin (DMAS) inhibits cell viability and induces apoptosis in human lung adenocarcinoma cells. A, Chemical structure of DMAS. B, PC-9 cells were treated with DMAS for 24 and 48 h, and then cell viability was evaluated by MTT assay. C, PC-9 cells were treated with DMAS (15 lmol/L) for 24 h and then stained with DAPI solution. Morphological and nuclear changes were assessed by fluorescence microscopy. White arrows indicate condensed nuclei. D, After treatment with DMAS for 24 h, PC-9 cells were stained with Annexin V-FITC/propidium iodide (PI) and detected by flow cytometry analysis. E, PC-9 cells were treated with DMAS for 24 h. Expression levels of indicated proteins were detected by western blot assay. F, PC-9 cells were incubated with DMAS for 24 h with or without pretreatment with Z-VAD-FMK (10 lmol/L). Expression levels of indicated proteins were studied by western blot assay. All data are expressed as mean AE SD. *P < .05 compared to the control group. PARP, poly ADP ribose polymerase was obtained from Selleck Chemicals (Houston, TX, USA 
| MATERIALS AND METHODS

| Reagents and antibodies
DMAS (purchased from
Tokyo
| Cell viability assay
Effects of indicated agents on cell viability were studied through the MTT assay as described previously. 
| Monodansylcadaverine staining
Pretreated cells were washed with PBS, and incubated with a 50 lmol/L final concentration of MDC in PBS for 30 minutes at 37°C in the dark. After washing with PBS, the stained cells were fixed with 4% paraformaldehyde and then imaged immediately under a fluorescent microscope (Leica DM4000; Leica). 
| Transmission electron microscopy
| Statistical analysis
All experiments were repeated at least 3 times. Mean AE SD was calculated in each group. Statistical analysis was carried out with 1-way analysis of variance (ANOVA). Differences were considered statistically significant at *P < .05. Caspase activation is considered a hallmark of the early stages of apoptosis. 14 To examine whether DMAS-induced apoptosis is associated with caspase activation, cleavage of caspase-3, caspase-8, caspase-9, and PARP was detected using western blot assay. We found that exposure of PC-9 cells to DMAS resulted in a dose-dependent increase in the cleavage of caspase-3, caspase-8, and caspase-9
( Figure 1E ). Cleaved PARP, which is a substrate of caspase-3 and well-known apoptotic hallmark, was also increased with increasing concentrations of DMAS ( Figure 1E ). To further confirm the role of caspase activation in DMAS-induced apoptosis, we pretreated PC-9 cells with the pan-caspase inhibitor Z-VAD-FMK (10 lmol/L) prior to DMAS treatment. DMAS-induced cleavage of caspase-3 and PARP was almost completely abolished by pretreatment with Z-VAD-FMK ( Figure 1F ). In light of these results, DMAS could induce apoptosis in human lung adenocarcinoma PC-9 cells through the caspase-dependent apoptotic pathway. Similarly, our previous study has also shown that DMAS induces apoptosis in a caspasedependent method in human lung adenocarcinoma A549 cells. 15 
| DMAS stimulates autophagy in human lung adenocarcinoma cells
To determine whether DMAS affects autophagy in human lung adenocarcinoma cells, several autophagic assays were conducted.
Initially, MDC staining was carried out and viewed under a fluorescence microscope. MDC is an autofluorescent base which selectively accumulates in acidic vesicular organelles and, therefore, is used as a specific marker for autophagolysosomes. 16, 17 As shown in Figure 2A , Because DMAS induces autophagy through the ER stress-related ATF4-CHOP and IRE1-TRAF2-JNK axes, we also observed cell F I G U R E 4 b,b-Dimethylacrylshikonin (DMAS) induces endoplasmic reticulum (ER) stress in human lung adenocarcinoma cells. PC-9 and A549 cells were incubated with DMAS for 24 h. Expression levels of indicated proteins were evaluated by western blot assay. All data are expressed as mean AE SD. *P < .05 compared to the control group F I G U R E 3 b,b-Dimethylacrylshikonin (DMAS) induces autophagy flux in human lung adenocarcinoma cells. A, PC-9 and A549 cells were transfected with control siRNA or Atg5 siRNA and subsequently exposed to DMAS (15 lmol/L) for 24 h. Expression levels of indicated proteins were examined by western blot assay. B, PC-9 and A549 cells were pretreated with 3-methyladenine (3-MA; 5 mmol/L) for 1 h, and then coincubated with DMAS (15 lmol/L) for another 24 h. Expression levels of indicated proteins were detected by western blot assay. C, PC-9 and A549 cells were pretreated with Bafilomycin A1 (20 nmol/L) for 1 h, and then cotreated with DMAS (15 lmol/L) for another 24 h. Expression levels of indicated proteins were analyzed by western blot assay. D, PC-9 and A549 cells were pretreated with chloroquine (CQ; 3 lmol/L) for 1 h, and then coincubated with DMAS (15 lmol/L) for another 24 h. Expression levels of indicated proteins were studied by western blot assay. All data are expressed as mean AE SD. *P < .05 compared to the control group apoptosis in CHOP-or ATF4-depleted cells treated with DMAS.
We knocked down CHOP or ATF4 expression by siRNA and then detected the cleavage of caspase-3 and PARP after treatment with DMAS (15 lmol/L) in PC-9 and A549 cells for 24 hours.
Expression levels of cleaved caspase-3 and cleaved PARP in CHOP-or ATF4-knockdown cells were augmented after treatment with DMAS compared with the control cells ( Figure 7A,B) . Furthermore, we evaluated the roles of combination treatment with DMAS and SP600125 (specific inhibitor for JNK) or 4-PBA (ER stress antagonist) on cell apoptosis in PC-9 and A549 cells. As shown in Figure 7C ,D, combination treatment using DMAS and SP600125 or 4-PBA significantly upregulated the expression levels of cleaved caspase-3 and cleaved PARP than that of DMAS treatment alone. However, the DMAS-induced cleavage of caspase-3
and PARP was not influenced by prior treatment with SP600125 in A549 cells ( Figure 7C ). Collectively, these data confirmed that autophagy contributed to protecting cells from DMAS-induced apoptosis in human lung adenocarcinoma cells.
| DISCUSSION
b,b-Dimethylacrylshikonin is a plant-derived natural product and shows strong anti-tumor effects. 6 We previously reported that DMAS inhibited growth and induced apoptosis in human gastric cancer SGC-7901 cells. 9 In the present study, we reported for the first time the multifaceted antitumor activities of DMAS on human lung adenocarcinoma cells. DMAS substantially decreased the viability of PC-9 cells in both dose-dependent and time-dependent methods.
Apoptosis, autophagy, as well as ER stress, were induced by DMAS treatment.
The induction of apoptosis is thought to be a key mechanism for most anti-tumor therapies. Caspases, a family of proteases, are responsible for the execution of apoptosis. 24 Flow cytometry with Growing evidence indicates that autophagy can be induced by activating ER stress. 19, 26, 27 ER stress activates the PERK-eIF2a-ATF4-CHOP and IRE1-TRAF2-JNK signaling axes of the UPR, which play a vital role in the regulation of ER stress-induced autophagy. 18 Actually, many anticancer compounds have been reported to function primarily through stimulation of ER stress. 28, 29 In our study, we
showed that DMAS could upregulate ER stress-associated proteins such as Bip, p-PERK, p-eIF2a, ATF4, CHOP, IRE1a and p-JNK in a dose-dependent way, and downregulate TRAF2 in a concentrationdependent way. Moreover, using siRNA against ATF4 or CHOP and inhibitors of ER stress in combination with DMAS, we confirmed that the PERK-eIF2a-ATF4-CHOP and IRE1-TRAF2-JNK signaling axes of the UPR were the crucial mediator of DMAS-induced autophagy in PC-9 and A549 cells. Collectively, these data showed that DMAS induced autophagy through activation of ER stress in human lung adenocarcinoma cells.
The pro-survival and pro-death functions of autophagy in cancer cells highly depend on cell types and inducers. 30, 31 In the present study, we investigated the relationship between autophagy and apoptosis in DMAS-treated PC-9 and A549 cells and
induces autophagy by endoplasmic reticulum (ER) stress-evoked PERK-eIF2a-ATF4-CHOP and IRE1-TRAF2-JNK upregulation. A, PC-9 and A549 cells were transfected with control siRNA or CHOP siRNA for 48 h, and then exposed to DMAS (15 lmol/L) for 24 h. Expression levels of indicated proteins were detected by western blot assay. B, PC-9 and A549 cells were transfected with control siRNA or ATF4 siRNA for 48 h, and then incubated with DMAS (15 lmol/L) for 24 h. Expression levels of indicated proteins were analyzed by western blot assay. C, PC-9 and A549 cells were pretreated with SP600125 (50 lmol/L) for 1 h, and then cotreated with DMAS (15 lmol/L) for another 24 h. Expression levels of indicated proteins were examined by western blot assay. D, PC-9 and A549 cells were pretreated with 4-phenylbutyrate (4-PBA; 5 mmol/L) for 30 min, and then cotreated with DMAS (15 lmol/L) for another 24 h. Expression levels of indicated proteins were studied by western blot assay. All data are expressed as mean AE SD. *P < .05 compared to the control group found that when combined with DMAS, apoptosis was enhanced upon knockdown of ATG5 by siRNA or in autophagy inhibitortreated cells, which indicates that autophagy contributes to promoting cell survival in DMAS-treated human lung adenocarcinoma cells.
To sum up, in the present research, we showed that DMAS induced autophagy through the ER stress response, which played a protective role against DMAS-induced apoptosis in human lung adenocarcinoma cells. Previous studies have reported that autophagy suppression may be a therapeutic approach for cancer Apoptotic cells were examined by Annexin V-FITC/PI staining assay. All data are expressed as mean AE SD. *P < .05 compared to the control group. PARP, poly ADP ribose polymerase treatment. 32, 33 We predict that combination treatment with DMAS and pharmacological autophagy inhibitors will be a safer and more effective therapeutic strategy for cancer treatment. 
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